New York's adult-use market gets most of the headlines, but the state just made meaningful changes to its medical cannabis program, too, and they matter for patients who rely on it.
What changed
At its July 2, 2026 meeting, the Cannabis Control Board approved a set of updates to the medical marijuana regulations. The headline change is a bigger possession limit: patients can now hold a 60-day supply, or up to three ounces of cannabis and 24 grams of concentrate, whichever is greater. That's a real jump from the tighter caps patients dealt with before.
The board also extended how long a patient certification lasts, from one year to up to two years, meaning fewer trips back to a practitioner just to stay certified.
Out-of-state patients welcome
Perhaps the most notable shift: qualifying out-of-state medical patients will be able to buy from Registered Organization dispensing facilities in New York once the rules take effect. For a state that draws millions of visitors, that opens the medical system to patients who are certified elsewhere but need their medicine while in New York.
When it takes effect
The updates take effect upon publication of a Notice of Adoption in the New York State Register. Patients should confirm the current rules with their Registered Organization, since dispensing facilities apply the limits at the point of sale.
Why it matters
The medical program has sometimes felt like an afterthought as adult-use sales boomed, and some patients had drifted to the recreational side for convenience. These changes, higher limits, longer certifications, and out-of-state access, make the medical route more practical again, especially for people who need consistent, higher-volume access or specific product types. It's a quiet but real signal that New York still sees medical cannabis as a distinct, protected lane. Cannabis products are for adults 21+, and medical use requires a valid certification.